Elevated tear interleukin-6 and interleukin-8 levels in patients with conjunctivochalasis

Cornea

Volumn 28, Issue 2, 2009, Pages 189-193

  Erdogan Poyraz, Ceren ^a   Mocan, Mehmet C ^a   Bozkurt, Banu ^b   Gariboglu, Semra ^a   Irkec, Murat ^a   Orhan, Mehmet ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

Conjunctivochalasis; Inflammation; Interleukin 6; Interleukin 8

Indexed keywords

FLUORESCEIN; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONJUNCTIVA DISEASE; CONJUNCTIVOCHALASIS; CONTROLLED STUDY; DISEASE SEVERITY; DRY EYE; FEMALE; HUMAN; LACRIMAL FLUID; MAJOR CLINICAL STUDY; MALE; OCCLUSION; OCULAR SURFACE DISEASE INDEX; PRIORITY JOURNAL; SYMPTOM;

AGED; CONJUNCTIVAL DISEASES; FEMALE; FLUORESCEIN; FLUORESCENT DYES; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TEARS;

EID: 67650585866     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181861d0c     Document Type: Article

References (26)

1. Liu D. Conjunctivochalasis. A cause of tearing and its management. Ophthal Plast Reconstr Surg. 1986;2:25-28.
2. Meller D, Tseng SCG. Conjunctivochalasis: literature review and possible pathophysiology. Surv Ophthalmol. 1998;43:225-232.
3. Yokoi N, Komuro A, Maruyama K, et al. New surgical treatment for superior limbic keratoconjunctivitis and its association with conjuncti-vochalasis. Am J Ophthalmol. 2003;135:303-308.
4. Kheirkhah A, Casas V, Esquenazi S, et al. New surgical approach for superior conjunctivochalasis. Cornea. 2007;26:685-691.
5. Yokoi N, Komuro A, Nishii M, et al. Clinical impact of conjunctivocha-lasis on the ocular surface. Cornea. 2005;24:S24-S31.
6. Di Pascuale MA, Espana EM, Kawakita T, et al. Clinical characteristics of conjunctivochalasis with or without aqueous tear deficiency. Br J Ophthalmol. 2004;88:388-392.
7. Erdogan-Poyraz C, Mocan MC, Irkec M, et al. Delayed tear clearance in patients with conjunctivochalasis is associated with punctal occlusion. Cornea. 2007;26:290-293.
8. Wang Y, Dogru M, Matsumoto Y, et al. The impact of nasal conjunctivochalasis on tear functions and ocular surface findings. Am J Ophthalmol. 2007;144:930-937.
9. Watanabe A, Yokoi N, Kinoshita S, et al. Clinicopathologic study of conjunctivochalasis. Cornea. 2004;23:294-298.
10. Francis IC, Chan DG, Kim P, et al. Case-controlled clinical and histopathological study of conjunctivochalasis. Br J Ophthalmol. 2005; 89:302-305.
11. Yoon KC, Jeong IY, Park YG, et al. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea. 2007;26:431-437.
12. Ang LP, Sotozono C, Koizumi N, et al. A comparison between cultivated and conventional limbal stem cell transplantation for Stevens-Johnson syndrome. Am J Ophthalmol. 2007;143:178-180.
13. Ongkosuwito JV, Feron EJ, van Doornik CE, et al. Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis. Invest Ophthalmol Vis Sci. 1998;39:2659-2665.
14. Fenton RR, Molesworth-Kenyon S, Oakes JE, et al. Linkage of IL-6 with neutrophil chemoattractant expression in virus-induced ocular inflammation. Invest Ophthalmol Vis Sci. 2002;43:737-743.
15. Kallinikos P, Morgan P, Efron N. Assessment of stromal keratocytes and tear film inflammatory mediators during extended wear of contact lenses. Cornea. 2006;25:1-10.
16. Thakur A, Willcox MD. Contact lens wear alters the production of certain inflammatory mediators in tears. Exp Eye Res. 2000;70: 255-259.
17. Walt JG, Rowe MM, Stern KL. Evaluating the functional impact of dry eye: the ocular surface disease index [abstract]. Drug Inf J. 1997; 31:1436.
18. Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118: 615-621.
19. Prabhasawat P, Tseng SCG. Frequent association of delayed tear clearance in ocular irritation. Br J Ophthalmol. 1998;82:666-675.
20. Uchino E, Sonoda S, Kinukawa N, et al. Alteration pattern of tear cytokines during the course of a day: diurnal rhythm analyzed by multicytokine assay. Cytokine. 2006;33:36-40.
21. Meller D, Li D, Tseng SCG. Regulation of collagenase, stromelysin and gelatinase B in human conjunctival and conjunctivochalasis fibroblasts by interleukin-1β and tumor necrosis factor-α. Invest Ophthalmol Vis Sci. 2000;41:2922-2929.
22. Li D, Meller D, Liu Y, et al. Overexpression of MMP-1 and MMP-3 by cultured conjunctivochalasis fibroblasts. Invest Ophthalmol Vis Sci. 2000; 41:404-410.
23. Di Girolamo N, Kumar RK, Coroneo MT, et al. UVB-mediated induction of interleukin-6 and -8 in pterygia and cultured human pterygium epithelial cells. Invest Ophthalmol Vis Sci. 2002;43:3430- 3437.
24. Kishimoto K. The biology of interleukin 6. Blood. 1989;74:1-10.
25. Luca M, Huang S, Gershenwald JE, et al. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol. 1997;151:1105-1113.
26. Ito A, Itoh Y, Sasaguri Y, et al. Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts. Arthritis Rheum. 1992;35:1197-1201.